226 related articles for article (PubMed ID: 25875108)
1. Deletion of histone deacetylase 7 in osteoclasts decreases bone mass in mice by interactions with MITF.
Stemig M; Astelford K; Emery A; Cho JJ; Allen B; Huang TH; Gopalakrishnan R; Mansky KC; Jensen ED
PLoS One; 2015; 10(4):e0123843. PubMed ID: 25875108
[TBL] [Abstract][Full Text] [Related]
2. HDAC3 and HDAC7 have opposite effects on osteoclast differentiation.
Pham L; Kaiser B; Romsa A; Schwarz T; Gopalakrishnan R; Jensen ED; Mansky KC
J Biol Chem; 2011 Apr; 286(14):12056-65. PubMed ID: 21324898
[TBL] [Abstract][Full Text] [Related]
3. HDAC7 inhibits osteoclastogenesis by reversing RANKL-triggered β-catenin switch.
Jin Z; Wei W; Dechow PC; Wan Y
Mol Endocrinol; 2013 Feb; 27(2):325-35. PubMed ID: 23204328
[TBL] [Abstract][Full Text] [Related]
4. Microphthalmia transcription factor regulates the expression of the novel osteoclast factor GPNMB.
Ripoll VM; Meadows NA; Raggatt LJ; Chang MK; Pettit AR; Cassady AI; Hume DA
Gene; 2008 Apr; 413(1-2):32-41. PubMed ID: 18313864
[TBL] [Abstract][Full Text] [Related]
5. MS-275, a benzamide histone deacetylase inhibitor, prevents osteoclastogenesis by down-regulating c-Fos expression and suppresses bone loss in mice.
Kim HN; Lee JH; Jin WJ; Ko S; Jung K; Ha H; Lee ZH
Eur J Pharmacol; 2012 Sep; 691(1-3):69-76. PubMed ID: 22846626
[TBL] [Abstract][Full Text] [Related]
6. Interferon-β-induced miR-155 inhibits osteoclast differentiation by targeting SOCS1 and MITF.
Zhang J; Zhao H; Chen J; Xia B; Jin Y; Wei W; Shen J; Huang Y
FEBS Lett; 2012 Sep; 586(19):3255-62. PubMed ID: 22771905
[TBL] [Abstract][Full Text] [Related]
7. HSP90 inhibitors enhance differentiation and MITF (microphthalmia transcription factor) activity in osteoclast progenitors.
van der Kraan AG; Chai RC; Singh PP; Lang BJ; Xu J; Gillespie MT; Price JT; Quinn JM
Biochem J; 2013 Apr; 451(2):235-44. PubMed ID: 23379601
[TBL] [Abstract][Full Text] [Related]
8. SLIT2 inhibits osteoclastogenesis and bone resorption by suppression of Cdc42 activity.
Park SJ; Lee JY; Lee SH; Koh JM; Kim BJ
Biochem Biophys Res Commun; 2019 Jun; 514(3):868-874. PubMed ID: 31084928
[TBL] [Abstract][Full Text] [Related]
9. The mammalian lectin galectin-8 induces RANKL expression, osteoclastogenesis, and bone mass reduction in mice.
Vinik Y; Shatz-Azoulay H; Vivanti A; Hever N; Levy Y; Karmona R; Brumfeld V; Baraghithy S; Attar-Lamdar M; Boura-Halfon S; Bab I; Zick Y
Elife; 2015 May; 4():e05914. PubMed ID: 25955862
[TBL] [Abstract][Full Text] [Related]
10. Rho-GEF trio regulates osteoclast differentiation and function by Rac1/Cdc42.
Gu J; Yang Z; Yuan L; Guo S; Wang D; Zhao N; Meng L; Liu H; Chen W; Ma J
Exp Cell Res; 2020 Nov; 396(1):112265. PubMed ID: 32898553
[TBL] [Abstract][Full Text] [Related]
11. ATF3 controls proliferation of osteoclast precursor and bone remodeling.
Fukasawa K; Park G; Iezaki T; Horie T; Kanayama T; Ozaki K; Onishi Y; Takahata Y; Yoneda Y; Takarada T; Kitajima S; Vacher J; Hinoi E
Sci Rep; 2016 Aug; 6():30918. PubMed ID: 27480204
[TBL] [Abstract][Full Text] [Related]
12. Targeted disruption of ephrin B1 in cells of myeloid lineage increases osteoclast differentiation and bone resorption in mice.
Cheng S; Zhao SL; Nelson B; Kesavan C; Qin X; Wergedal J; Mohan S; Xing W
PLoS One; 2012; 7(3):e32887. PubMed ID: 22403721
[TBL] [Abstract][Full Text] [Related]
13. Failure to Target RANKL Signaling Through p38-MAPK Results in Defective Osteoclastogenesis in the Microphthalmia Cloudy-Eyed Mutant.
Carey HA; Bronisz A; Cabrera J; Hildreth BE; Cuitiño M; Fu Q; Ahmad A; Toribio RE; Ostrowski MC; Sharma SM
J Cell Physiol; 2016 Mar; 231(3):630-40. PubMed ID: 26218069
[TBL] [Abstract][Full Text] [Related]
14. Immune complex-induced inhibition of osteoclastogenesis is mediated via activating but not inhibitory Fcγ receptors on myeloid precursor cells.
Grevers LC; de Vries TJ; Everts V; Verbeek JS; van den Berg WB; van Lent PL
Ann Rheum Dis; 2013 Feb; 72(2):278-85. PubMed ID: 22918932
[TBL] [Abstract][Full Text] [Related]
15. Baicalin positively regulates osteoclast function by activating MAPK/Mitf signalling.
Lu L; Rao L; Jia H; Chen J; Lu X; Yang G; Li Q; Lee KKH; Yang L
J Cell Mol Med; 2017 Jul; 21(7):1361-1372. PubMed ID: 28158928
[TBL] [Abstract][Full Text] [Related]
16. Chloroform extract of deer antler inhibits osteoclast differentiation and bone resorption.
Li YJ; Kim TH; Kwak HB; Lee ZH; Lee SY; Jhon GJ
J Ethnopharmacol; 2007 Sep; 113(2):191-8. PubMed ID: 17646068
[TBL] [Abstract][Full Text] [Related]
17. Trichostatin A inhibits osteoclastogenesis and bone resorption by suppressing the induction of c-Fos by RANKL.
Kim HN; Ha H; Lee JH; Jung K; Yang D; Woo KM; Lee ZH
Eur J Pharmacol; 2009 Nov; 623(1-3):22-9. PubMed ID: 19766111
[TBL] [Abstract][Full Text] [Related]
18. Hyaluronan inhibits osteoclast differentiation via Toll-like receptor 4.
Chang EJ; Kim HJ; Ha J; Kim HJ; Ryu J; Park KH; Kim UH; Lee ZH; Kim HM; Fisher DE; Kim HH
J Cell Sci; 2007 Jan; 120(Pt 1):166-76. PubMed ID: 17164294
[TBL] [Abstract][Full Text] [Related]
19. The expression of Clcn7 and Ostm1 in osteoclasts is coregulated by microphthalmia transcription factor.
Meadows NA; Sharma SM; Faulkner GJ; Ostrowski MC; Hume DA; Cassady AI
J Biol Chem; 2007 Jan; 282(3):1891-904. PubMed ID: 17105730
[TBL] [Abstract][Full Text] [Related]
20. FHL2 inhibits the activated osteoclast in a TRAF6-dependent manner.
Bai S; Kitaura H; Zhao H; Chen J; Müller JM; Schüle R; Darnay B; Novack DV; Ross FP; Teitelbaum SL
J Clin Invest; 2005 Oct; 115(10):2742-51. PubMed ID: 16184196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
